ABAB ScienceAB info
$1.15info0.39%24h
Global rank24444
Market cap$57.13M
Change 7d-1.14%
YTD Performance-71.09%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    AB Science (AB) Stock Overview

    AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

    AB Stock Information

    Symbol
    AB
    Address
    3, avenue George VParis, 75008France
    Founded
    -
    Trading hours
    -
    Website
    https://www.ab-science.com
    Country
    🇫🇷 France
    Phone Number
    33 1 47 20 00 14

    AB Science (AB) Price Chart

    -
    Value:-

    AB Science Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.15
    N/A
    Market Cap
    $57.13M
    N/A
    Shares Outstanding
    49.52M
    N/A
    Employees
    89.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org